Maze Therapeutics, Inc. ( MAZE) - Stock Earnings
MAZE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 18, 2026, midnight | — / — | — | — / — | — |
MAZE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -34.6 million USD | — USD |
| 2026Q1 | -24.2 million USD | 20.0 million USD |
| 2026Q2 | -44.7 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
MAZE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -100.4 million USD | — USD |
| 2024 | 52.2 million USD | 167.5 million USD |
| 2025 | -131.1 million USD | — USD |
| 2026 Est. | — | — |
MAZE
Price: $28.93
52 week price:
Earnings Per Share: -2.37 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.5 billion